Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Fabrazyme (agalsidase beta) is a man-made form of the naturally-occurring alpha-galactosidase A enzyme. A deficiency of this enzyme is called Fabry disease. Agalsidase beta reduces deposits of globotriaosylceramide (GL-3) in the kidneys and certain other cells in the body. Fabrazyme is used in the treatment of Fabry disease.
This report elaborates on the current development of the Fabrazyme-Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
GlaxoSmithKline
Sanofi-Genzyme
Amgen Inc
Protalix Biotherapeutics
Shire
Novartis Pharmaceuticals
By Type:
White Lyophilized Powder
White Lyophilized Cake
By Application:
Fabry Disease
Other Disease
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Fabrazyme-Drug Market Overview 2018-2029
-
1.1 China Fabrazyme-Drug Industry Development Overview
-
1.2 China Fabrazyme-Drug Industry Development History
-
1.3 China Fabrazyme-Drug Industry Market Size (2018-2029)
-
1.4 China Fabrazyme-Drug Market Analysis by Type from Production Side
-
1.4.1 China Fabrazyme-Drug Production Volume, Production Value and Growth Rate of White Lyophilized Powder (2018-2029)
-
1.4.2 China Fabrazyme-Drug Production Volume, Production Value and Growth Rate of White Lyophilized Cake (2018-2029)
-
1.5 China Fabrazyme-Drug Market Analysis by Application from Consumption End
-
1.5.1 China Fabrazyme-Drug Sales Volume, Sales Value and Growth Rate of Fabry Disease (2018-2029)
-
1.5.2 China Fabrazyme-Drug Sales Volume, Sales Value and Growth Rate of Other Disease (2018-2029)
-
1.6 China Fabrazyme-Drug Market Analysis by Region
-
1.6.1 North China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Fabrazyme-Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Fabrazyme-Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Fabrazyme-Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Fabrazyme-Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Fabrazyme-Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Fabrazyme-Drug Industry Development
Chapter 3 Fabrazyme-DrugIndustry Chain Analysis
-
3.1 Fabrazyme-Drug Industry Chain
-
3.2 Fabrazyme-Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Fabrazyme-Drug Market
-
3.3 Fabrazyme-Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Fabrazyme-Drug Market
Chapter 4 China Fabrazyme-Drug Market, by Type
-
4.1 China Fabrazyme-Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Fabrazyme-Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Fabrazyme-Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Fabrazyme-Drug Production Volume and Growth Rate of White Lyophilized Powder
-
4.5.2 China Fabrazyme-Drug Production Volume and Growth Rate of White Lyophilized Cake
Chapter 5 China Fabrazyme-Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Fabrazyme-Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Fabrazyme-Drug Market Size and Growth Rate, by Application
-
5.5.1 China Fabrazyme-Drug Market Size and Growth Rate of Fabry Disease
-
5.5.2 China Fabrazyme-Drug Market Size and Growth Rate of Other Disease
Chapter 6 China Fabrazyme-Drug Market, by Region
-
6.1 China Fabrazyme-Drug Production Volume and Production Value, by Region
-
6.2 China Fabrazyme-Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Fabrazyme-Drug Market Analysis
-
7.1 North China Fabrazyme-Drug Market, by Type
-
7.2 North China Fabrazyme-Drug Market, by Application
Chapter 8 Central China Fabrazyme-Drug Market Analysis
-
8.1 Central China Fabrazyme-Drug Market, by Type
-
8.2 Central China Fabrazyme-Drug Market, by Application
Chapter 9 South China Fabrazyme-Drug Market Analysis
-
9.1 South China Fabrazyme-Drug Market, by Type
-
9.2 South China Fabrazyme-Drug Market, by Application
Chapter 10 East China Fabrazyme-Drug Market Analysis
-
10.1 East China Fabrazyme-Drug Market, by Type
-
10.2 East China Fabrazyme-Drug Market, by Application
Chapter 11 Northeast China Fabrazyme-Drug Market Analysis
-
11.1 Northeast China Fabrazyme-Drug Market, by Type
-
11.2 Northeast China Fabrazyme-Drug Market, by Application
Chapter 12 Southwest China Fabrazyme-Drug Market Analysis
-
12.1 Southwest China Fabrazyme-Drug Market, by Type
-
12.2 Southwest China Fabrazyme-Drug Market, by Application
Chapter 13 Northwest China Fabrazyme-Drug Market Analysis
-
13.1 Northwest China Fabrazyme-Drug Market, by Type
-
13.2 Northwest China Fabrazyme-Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Profile
-
14.1.2 GlaxoSmithKline Fabrazyme-Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Sanofi-Genzyme
-
14.2.1 Sanofi-Genzyme Company Profile
-
14.2.2 Sanofi-Genzyme Fabrazyme-Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Amgen Inc
-
14.3.1 Amgen Inc Company Profile
-
14.3.2 Amgen Inc Fabrazyme-Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Protalix Biotherapeutics
-
14.4.1 Protalix Biotherapeutics Company Profile
-
14.4.2 Protalix Biotherapeutics Fabrazyme-Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Shire
-
14.5.1 Shire Company Profile
-
14.5.2 Shire Fabrazyme-Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis Pharmaceuticals
-
14.6.1 Novartis Pharmaceuticals Company Profile
-
14.6.2 Novartis Pharmaceuticals Fabrazyme-Drug Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Fabrazyme-Drug Industry Research Conclusions
-
15.2 Fabrazyme-Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Fabrazyme-Drug Industry Market Size (2018-2029)
-
Figure China Fabrazyme-Drug Production Volume, Production Value and Growth Rate of White Lyophilized Powder (2018-2029)
-
Figure China Fabrazyme-Drug Production Volume, Production Value and Growth Rate of White Lyophilized Cake (2018-2029)
-
Figure China Fabrazyme-Drug Sales Volume, Sales Value and Growth Rate of Fabry Disease (2018-2029)
-
Figure China Fabrazyme-Drug Sales Volume, Sales Value and Growth Rate of Other Disease (2018-2029)
-
Figure North China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Fabrazyme-Drug Market Size and Growth Rate from 2018-2029
-
Figure Fabrazyme-Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Fabrazyme-Drug Market Share by Type in 2018
-
Figure China Fabrazyme-Drug Market Share by Type in 2023
-
Figure China Fabrazyme-Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Fabrazyme-Drug Production Volume and Growth Rate of White Lyophilized Powder (2018-2023)
-
Figure China Fabrazyme-Drug Production Volume and Growth Rate of White Lyophilized Cake (2018-2023)
-
Figure China Fabrazyme-Drug Market Share by Application in 2018
-
Figure China Fabrazyme-Drug Market Share by Application in 2023
-
Figure China Fabrazyme-Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Fabrazyme-Drug Market Size and Growth Rate of Fabry Disease (2018-2023)
-
Figure China Fabrazyme-Drug Market Size and Growth Rate of Other Disease (2018-2023)
-
Table China Fabrazyme-Drug Production Volume by Region (2018-2023)
-
Table China Fabrazyme-Drug Production Volume Share by Region (2018-2023)
-
Figure China Fabrazyme-Drug Production Volume Share by Region (2018-2023)
-
Table China Fabrazyme-Drug Production Value by Region (2018-2023)
-
Table China Fabrazyme-Drug Production Value Share by Region (2018-2023)
-
Figure China Fabrazyme-Drug Production Value Share by Region (2018-2023)
-
Table China Fabrazyme-Drug Sales Volume by Region (2018-2023)
-
Table China Fabrazyme-Drug Sales Volume Share by Region (2018-2023)
-
Figure China Fabrazyme-Drug Sales Volume Share by Region (2018-2023)
-
Table China Fabrazyme-Drug Sales Value by Region (2018-2023)
-
Table China Fabrazyme-Drug Sales Value Share by Region (2018-2023)
-
Figure China Fabrazyme-Drug Sales Value Share by Region (2018-2023)
-
Table North China Fabrazyme-Drug Production Volume by Type (2018-2023)
-
Table North China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Figure North China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Table North China Fabrazyme-Drug Sales Volume by Application (2018-2023)
-
Table North China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Fabrazyme-Drug Production Volume by Type (2018-2023)
-
Table Central China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Table Central China Fabrazyme-Drug Sales Volume by Application (2018-2023)
-
Table Central China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Table South China Fabrazyme-Drug Production Volume by Type (2018-2023)
-
Table South China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Figure South China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Table South China Fabrazyme-Drug Sales Volume by Application (2018-2023)
-
Table South China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Table East China Fabrazyme-Drug Production Volume by Type (2018-2023)
-
Table East China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Figure East China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Table East China Fabrazyme-Drug Sales Volume by Application (2018-2023)
-
Table East China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Fabrazyme-Drug Production Volume by Type (2018-2023)
-
Table Northeast China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Fabrazyme-Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Fabrazyme-Drug Production Volume by Type (2018-2023)
-
Table Southwest China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Fabrazyme-Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Fabrazyme-Drug Production Volume by Type (2018-2023)
-
Table Northwest China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Fabrazyme-Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Fabrazyme-Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Fabrazyme-Drug Sales Volume Share by Application (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Fabrazyme-Drug Revenue, Price and Gross (2018-2023)
-
Table Sanofi-Genzyme Company Profile
-
Table Sanofi-Genzyme Fabrazyme-Drug Revenue, Price and Gross (2018-2023)
-
Table Amgen Inc Company Profile
-
Table Amgen Inc Fabrazyme-Drug Revenue, Price and Gross (2018-2023)
-
Table Protalix Biotherapeutics Company Profile
-
Table Protalix Biotherapeutics Fabrazyme-Drug Revenue, Price and Gross (2018-2023)
-
Table Shire Company Profile
-
Table Shire Fabrazyme-Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Pharmaceuticals Company Profile
-
Table Novartis Pharmaceuticals Fabrazyme-Drug Revenue, Price and Gross (2018-2023)
-
